RecruitingPhase 3NCT03368092
Rare condition
Adult acute respiratory distress syndrome
14
studies recruiting now
as of 7 Sept 2026
241
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
25 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07070362
Digital Early Warning System for Acute Lung Injury in Liver Surgery
RecruitingNot applicableNCT07669558
Electrical Impedance Tomography-Guided Identification of the Optimal Lateral Position in Postoperative ARDS
RecruitingPhase 2NCT06513949
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
RecruitingNCT07225257
Recovery of Physical Function After Critical Illness In Older Adults
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 14 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Adult acute respiratory distress syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Adult acute respiratory distress syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 17 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Vilobelimab
Phase 3Calfactant (Infasurf)
Phase 3Interferon Beta-1a (Avonex)
Phase 3Dornase Alfa (Pulmozyme)
Phase 3Iloprost (Aurlumyn)
Phase 2/3Albuterol Sulfate (Accuneb)
Phase 2Treprostinil (Remodulin)
Phase 2Plasmalyte A
Phase 2Roflumilast (Daliresp)
+ 9 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).